SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: Dan Spillane who wrote (2160)6/13/1999 12:04:00 AM
From: Anthony Wong  Respond to of 2539
 
Biotech seen as solution, problem
BY ART HOVEY Lincoln Journal Star

James Tobin's world is filled with visions of higher-starch French fries that
absorb less cooking oil, with margarine that is free of harmful acids, with
better chances to harvest "a really terrific crop." Fred Kirschenmann's
world is filled with doubts about treadmill technology, industrialized
farmers and "therapeutic intervention" to thwart plant pests.

Want to guess who's on the cutting edge of Monsanto's biotechnology
blitz and who's in the resister's camp?

Even without the requisite introductions and name tags, there would have
been no need for guesswork on the backgrounds of two of the featured
speakers at the second day of the three-day National Agricultural
Biotechnology Council meeting in Lincoln Monday.

Tobin, leader of Monsanto's global seed company, promoted genetically
engineered crops as a solution to a variety of problems, including world
hunger.

"Our ability to produce better-quality food will be impacted dramatically
by biotechnology," he told a Cornhusker hotel audience of more than
100, including representatives of more than two-dozen teaching and
research universities, among them Cornell, the University of California and
the University of Nebraska.

"We're not taking away the choices they have today," Tobin said of
farmers. "We're giving them new choices." That includes plants specially
endowed to resist weeds and insects and to produce more nutritional
value.

But Kirschenmann, North Dakota-based manager of Kirschenmann
Family Farms, thinks the organic approach to agriculture is the more
prudent and sustainable course. He listed poor soybean prices in the
United States as one problem. He also cited profit-driven shipments of
genetically enhanced Brazilian soybeans away from that country's hungry
human population and toward European and Japanese livestock.

"This is not a formula that feeds the world or brings benefits to most
American farmers," he said.

Highly specialized approaches to weed and insect problems lead to such
problems as resistant strains and higher dosages to get the same results.
"While that certainly benefits the company that sells the solution, it hardly
benefits the farmer." Helping give some dimension to Monday's debate is
a recent controversy in which a genetically engineered insect toxin
implanted in corn to kill corn borers has been blamed for killing monarch
butterflies instead.

Tobin called tests that killed butterfly larvae "unrealistic," because the
testing conditions involved corn pollen on milkweed. He said chemicals
typically keep milkweed out of cornfields, corn pollen does not travel far
from fields and the pollen-shedding season lasts only five to seven days.

Monday's contrasting industry and farmer perspective fit in nicely with a
tradition dating back to the council's 1988 founding and to a commitment
spokeswoman Jane Baker Segelken described as "to come together to
listen and to learn." But some in the audience, including Dennis Avery of
the Hudson Institute's Center for Global Food Issues, obviously preferred
one message to the other.

He was skeptical of Kirschenmann's suggestions of a connection between
artificially enhanced food and rising health care costs, including 42 percent
of American children regularly taking prescription drugs.

According to Avery, use of the health care system and prescription drugs
is up "because we've got lots of dough and a lot of prescription drugs." If
it's available, consumers want it, he said. "I even invest in Viagra, and it's
expensive and it's worth it."

journalstar.com:80/archives/060899/neb/stox



To: Dan Spillane who wrote (2160)6/13/1999 10:51:00 AM
From: Anthony Wong  Read Replies (2) | Respond to of 2539
 
Gene food escapes health tests

Date: 12/06/99

By MARK RAGG

There are no plans to test the safety of genetically modified foods for humans, either before or after their release. Neither are there plans to test the safety of the hundreds of genetically modified foods already on the market.

In a series of interviews this week, government food regulators and plant scientists developing the foods said such testing was neither necessary nor feasible. However, doctors and public health groups said they were both essential and practical.

Dr Lisa Kelly, head of the biotechnology section at the Australian and New Zealand Food Authority, which has the combined roles of food regulator and food industry promoter, said clinical trials were certainly not needed to establish safety.

"Traditionally, we operate on the basis of reasonable certainty of no harm," Dr Kelly said. "Foods are assumed to be safe until proven otherwise."

The authority asked industry to perform a series of studies, including animal studies at times, to show that genetically modified foods were similar to existing foods. With that evidence, testing in humans was not required, she said.

Professor Nancy Millis, chair of the Genetic Manipulation Advisory Committee, which regulates the use of genetically modified crops and organisms, said clinical trials were unnecessary.

"You'd have to expose enormous numbers of people who would be prepared to go on diets," Professor Millis said. "This wouldn't be appropriate unless you had good reason to believe genetically modified foods harmful. And you have to ask - what reasons are there to believe the
foods are harmful?"

Dr T.J. Higgins, senior scientist with the CSIRO's Division of Plant Industry, which is developing genetically modified crops for food, said: "We have never done clinical trials. I can not see any possible reason for doing clinical trials on food, and to add to the cost in that way. We go from the starting point that most food is safe and nutritious. With genetically modified food, we ask: 'What do we think might be different?' If there's nothing different, why do clinical trials?" Dr Geoffrey Annison, scientific and technical director of the Australian Food and Grocery Council, said: "There is absolutely no evidence that genetic technology represents any greater risks than traditional breeding methods." Mr Brian Arnst, a spokesman for Monsanto, the world's largest manufacturer of genetically modified organisms, laughed when asked whether human trials were needed. "By
inserting one gene, we're actually changing things less than in traditional breeding, where lots of genes are changed."

However, these views are not supported by groups working in human health. Professor Fran Baum, president of the Public Health Association of Australia, called for a moratorium on the sale of genetically modified foods until their safety for people was proved. "You see, you don't actually need genetically modified foods," Professor Baum said. "They're not necessary. We believe you should invoke the precautionary principle - why not wait and see until they're proved safe? And it's not just foods. It's about the side-effects of genetically modified crops and their effects on the
environment. We just don't know what it's going to be." The vice-present of the Australian Medical Association, Dr Sandra Hacker, said she wondered how scientists could be so certain.

"The arguments about safety aren't in yet," Dr Hacker said. "I'm surprised people are so confident that no scientific endeavour at all is thought necessary. Actually, I'm quite amazed.

"Philosophically, it's a strange stance. They're saying we don't need to look at this. Why not? One must ask whether or not there's any pressure on the scientists from big business."

Professor Stewart Truswell, emeritus professor of human nutrition at Sydney University, said the safety of genetically modified foods was unknown, and could not be known for a long time. "Everyone is saying, 'For God's sake, slow down'. I totally support that view," Professor Truswell said.

Regarding human trials, he believed they would be necessary in some cases, while not in others. "It all depends on what you've done. But if you've made something dangerous to insects, and to other animals, how do you know it's not dangerous to humans?" Dr John Coveney, a senior lecturer in public health at Flinders University, said short-term testing in humans was quite practical and totally necessary.

"What we're talking about is an entirely new method of producing food," he said. "We can't possibly predict the outcome on human health. I'm staggered to hear people say that testing on humans is not required."

Dr Coveney said more complete animal testing of all genetically modified products was the first step required. Then, if proved safe, human trials were needed. "There's a fairly well understood procedure that is used if you want to register a new drug. It could quite easily be followed with foods." Volunteers could be divided into three groups - one to eat a genetically modified food such as soybeans, one to eat normal soybeans and one to avoid soybeans altogether. Blood tests could check on the function of the liver, kidney and immune system, and for any allergic responses. General health could be monitored.

"That's fairly standard," Dr Coveney said. "I don't think it's too much to ask for, considering we're dealing with something that's very, very new."

Professor John Simes, director of the National Health and Medical Research Council's Clinical Trials Centre, said large-scale, long-term trials were difficult but possible, as long as labelling was comprehensive.

"I think it's a sufficiently important issue - we're drastically changing the way food is being produced. Assuming the human race is going to be around for millions of years, we really need to understand the implications."

This material is subject to copyright and any unauthorised use, copying or mirroring is prohibited.


smh.com.au:80/news/9906/12/text/national12.html